drugset / Trial / NCT00031928

Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

NCT00031928

Phase 1 Completed 3000 enrolled National Cancer Institute (NCI)
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to determine the effectiveness of mafosfamide in treating patients who have progressive or refractory meningeal tumors.

Timeline

Start
2002-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Mafosfamide Small molecule Intrathecal